BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 18056795)

  • 41. The non-competitive antagonists 2-methyl-6-(phenylethynyl)pyridine and 7-hydroxyiminocyclopropan[b]chromen-1a-carboxylic acid ethyl ester interact with overlapping binding pockets in the transmembrane region of group I metabotropic glutamate receptors.
    Pagano A; Ruegg D; Litschig S; Stoehr N; Stierlin C; Heinrich M; Floersheim P; Prezèau L; Carroll F; Pin JP; Cambria A; Vranesic I; Flor PJ; Gasparini F; Kuhn R
    J Biol Chem; 2000 Oct; 275(43):33750-8. PubMed ID: 10934211
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-activity relationships for negative allosteric mGluR5 modulators.
    Kaae BH; Harpsøe K; Kvist T; Mathiesen JM; Mølck C; Gloriam D; Jimenez HN; Uberti MA; Nielsen SM; Nielsen B; Bräuner-Osborne H; Sauerberg P; Clausen RP; Madsen U
    ChemMedChem; 2012 Mar; 7(3):440-51. PubMed ID: 22267204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice.
    Galici R; Jones CK; Hemstapat K; Nong Y; Echemendia NG; Williams LC; de Paulis T; Conn PJ
    J Pharmacol Exp Ther; 2006 Jul; 318(1):173-85. PubMed ID: 16608916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Homology modeling of metabotropic glutamate receptors. (mGluRs) structural motifs affecting binding modes and pharmacological profile of mGluR1 agonists and competitive antagonists.
    Costantino G; Pellicciari R
    J Med Chem; 1996 Sep; 39(20):3998-4006. PubMed ID: 8831765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor.
    Steinfeld T; Mammen M; Smith JA; Wilson RD; Jasper JR
    Mol Pharmacol; 2007 Aug; 72(2):291-302. PubMed ID: 17478612
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Positive allosteric modulators of metabotropic glutamate 1 receptor: characterization, mechanism of action, and binding site.
    Knoflach F; Mutel V; Jolidon S; Kew JN; Malherbe P; Vieira E; Wichmann J; Kemp JA
    Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13402-7. PubMed ID: 11606768
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Allosteric Binding Site and Activation Mechanism of Class C G-Protein Coupled Receptors: Metabotropic Glutamate Receptor Family.
    Feng Z; Ma S; Hu G; Xie XQ
    AAPS J; 2015 May; 17(3):737-53. PubMed ID: 25762450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of metabotropic glutamate receptor 1 dimers requires glutamate binding in both subunits.
    Kammermeier PJ; Yun J
    J Pharmacol Exp Ther; 2005 Feb; 312(2):502-8. PubMed ID: 15466247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Venus fly trap domain of mGluR1 functions as a dominant negative against group I mGluR signaling.
    Beqollari D; Kammermeier PJ
    J Neurophysiol; 2010 Jul; 104(1):439-48. PubMed ID: 20463192
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 3-(Pyridin-2-yl-ethynyl)benzamide metabotropic glutamate receptor 5 negative allosteric modulators: hit to lead studies.
    Gilbert AM; Bursavich MG; Lombardi S; Adedoyin A; Dwyer JM; Hughes Z; Kern JC; Khawaja X; Rosenzweig-Lipson S; Moore WJ; Neal SJ; Olsen M; Rizzo SJ; Springer D
    Bioorg Med Chem Lett; 2011 Jan; 21(1):195-9. PubMed ID: 21126874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The peripheral role of group I metabotropic glutamate receptors on nociceptive behaviors in rats with knee joint inflammation.
    Lee KS; Kim J; Yoon YW; Lee MG; Hong SK; Han HC
    Neurosci Lett; 2007 Apr; 416(2):123-7. PubMed ID: 17314010
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cooperative signaling between homodimers of metabotropic glutamate receptors 1 and 5.
    Sevastyanova TN; Kammermeier PJ
    Mol Pharmacol; 2014 Nov; 86(5):492-504. PubMed ID: 25113912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabotropic glutamate receptor/phospholipase C system in female rat heart.
    Iglesias I; Castillo CA; León D; Ruíz MA; Albasanz JL; Martín M
    Brain Res; 2007 Jun; 1153():1-11. PubMed ID: 17493590
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Participation of peripheral group I and II metabotropic glutamate receptors in the development or maintenance of IL-1beta-induced mechanical allodynia in the orofacial area of conscious rats.
    Jung CY; Lee SY; Choi HS; Lim EJ; Lee MK; Yang GY; Han SR; Youn DH; Ahn DK
    Neurosci Lett; 2006 Dec; 409(3):173-8. PubMed ID: 17030435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure-activity relationship of triazafluorenone derivatives as potent and selective mGluR1 antagonists.
    Zheng GZ; Bhatia P; Daanen J; Kolasa T; Patel M; Latshaw S; El Kouhen OF; Chang R; Uchic ME; Miller L; Nakane M; Lehto SG; Honore MP; Moreland RB; Brioni JD; Stewart AO
    J Med Chem; 2005 Nov; 48(23):7374-88. PubMed ID: 16279797
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurophysiological signals as potential translatable biomarkers for modulation of metabotropic glutamate 5 receptors.
    Harvey BD; Siok CJ; Kiss T; Volfson D; Grimwood S; Shaffer CL; Hajós M
    Neuropharmacology; 2013 Dec; 75():19-30. PubMed ID: 23831682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Allosteric potentiators of metabotropic glutamate receptor subtype 1a differentially modulate independent signaling pathways in baby hamster kidney cells.
    Sheffler DJ; Conn PJ
    Neuropharmacology; 2008 Sep; 55(4):419-27. PubMed ID: 18625258
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration.
    Parmentier-Batteur S; O'Brien JA; Doran S; Nguyen SJ; Flick RB; Uslaner JM; Chen H; Finger EN; Williams TM; Jacobson MA; Hutson PH
    Neuropharmacology; 2012 Mar; 62(3):1453-60. PubMed ID: 21112344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential.
    Kew JN
    Pharmacol Ther; 2004 Dec; 104(3):233-44. PubMed ID: 15556676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inducible expression and pharmacological characterization of the mouse metabotropic glutamate 5b receptor.
    Salisbury BG; Mukhopadhyay G; Kostich M; Laz TM; Norris ED
    Eur J Pharmacol; 2008 Jan; 579(1-3):34-9. PubMed ID: 17967450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.